You are here: Home » Reuters » News
Business Standard

Sun Pharma tumbles after report of probe


(Reuters) - Shares of India's Sun Pharmaceutical Industries sank more than 10 percent on Monday after a report of a regulatory probe against the country's biggest drug manufacturer by market value.Markets regulator Securities and Exchange Board of India (SEBI) is likely to reopen an insider trading case against Sun, a report by the PTI carried in Indian daily Economic Times said.The SEBI will also probe alleged lapses by some of Sun's promoters in raising ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Mon, December 03 2018. 12:25 IST